Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

The Medicare coverage story of the Cardiomems device has a Homeric air about it, spanning nearly a decade starting with an adverse local coverage determination in 2016. Abbott Park, Ill.-based Abbott ...

With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies ...

The term "omics" refers to the study of the entirety of molecular mechanisms that happen inside an organism. With the advent ...

The proteomic blood test could be a noninvasive tool used to improve detection of the condition, which currently takes an average of 7.5 years to diagnose.

Sapient will be an Alamar certified service provider for Alamar's NULISAseq Inflammation panel and its NULISAseq CNS Disease panel.

Made in collaboration with Korean start-up Nanoentek, this tabletop device uses advanced proteomics (the study of how protein ...

Researchers at Case Western Reserve University School of Medicine have discovered how specific protein regions contribute to breast cancer.

Multi-omics integration combines genomics, proteomics, and more, offering a comprehensive view of complex biological systems ...

OncoHost, a global leader in next-generation precision oncology dedicated to advancing personalized cancer therapy, announced today that it has been named a winner in the 2025 BIG Innovation Awards.

Performing multi-omics analyses using a single sample is challenging in toxicology studies. Now, researchers propose a new ...

NULISA employs a sequential immunocomplex capture and release technique to improve the sensitivity of traditional proximity ...